March 17, 2025 06:36 ET | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S)
Please read the announcement in PDF
Attachment
COPENHAGEN, Denmark – February 26, 2026. Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year...
Please read the full announcement in PDF Attachment 2026_02_LTI ...
